Authors


Jonathan E. Levitt, Esq

Latest:

Prevent Potential Liability to State and Federal Agencies for "Excluded Providers"

Health care and pharmacy practices must regularly verify that their employees are not excluded from participation in Medicare, Medicaid, or other federal health programs.


Xianchen Liu, MD, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.



Larry Calemine, RPh, BS Pharm

Latest:

Reducing 30-day Readmission Rates Through Compliance Calls Post-Discharge

The discharge pharmacy service at West Virginia University (WVU) Medicine in Morgantown is intended to be a ‘patient first’ program that ensures patients receive the medications prescribed in hand, and that they remain adherent through medication counseling and followup.


Milton C. Weinstein, PhD

Latest:

Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving Chemotherapy

For US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.


Heather Dorsey

Latest:

The Expanding Roles of Genetic Counselors in Specialty Pharmacy Management

Currently, genetic counselors apply their molecular and clinical expertise in diverse roles, many delivered via telehealth.


Jessica Long, PharmD

Latest:

Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer Device

There is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.


Courtney Marabella

Latest:

National Comprehensive Cancer Network Issues Guidance on COVID-19 Vaccination for Patients With Cancer

NCCN states that all patients with active cancer, or with active, recent, or planned cancer treatment, should be considered highest priority to receive one of the COVID-19 vaccines granted emergency use authorization.


Parker Shay

Latest:

An Exciting Future for the Scope of Pharmacy Practice

Who would have thought that the girl who could not even swallow a pill at the age of 14 would pursue a career as a pharmacist?


Dallas Smith, PharmD Candidate

Latest:

An Indian Perspective on Opioids

To the dismay of many health care professionals, opioid abuse has become an epidemic in the United States.


Ralph P. Insinga, PhD

Latest:

Administration Costs of Denosumab and Zoledronic Acid for Postmenopausal Osteoporosis

This is the first study to report, in detail, patterns of resource use and costs associated with real-world administration of denosumab and zoledronic acid.


Bradley W. Howard, Esq

Latest:

Working with Pharmacy Employees: Mistakes to Avoid

An overview of the most common human resources problems that pharmacies face and the proactive steps that pharmacies can take to avoid these problems.


Meredith B. Rosenthal, PhD

Latest:

Incentive Formularies: Spending and Utilization for 3 Common Drug Classes

Incentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.




Richard Vuu, PharmD Candidate

Latest:

Insulin Pump Therapy and Continuous Glucose Monitoring

Insulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.


Jeff T. White, PharmD, MS

Latest:

Analyzing the Impact of Different Value-Based Insurance Design Programs

Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.


Philip P. Gerbino, PharmD

Latest:

Impact of Initial Days' Supply of Angiotensin II Receptor Blockers

For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.


Alternate Care Sales for Specialty Pharmaceutical Distribution at Cardinal Health

Latest:

Uncovering Hidden Savings in the Hospital Pharmacy

The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.


Tao He, MS

Latest:

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.


Hoytin T. Lee Ghin, BSPharm, PharmD, BCPS

Latest:

Overactive Bladder Disease: Overcoming the Urge to Go

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.


Brian C. Sauer, PhD

Latest:

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.


Stella Quenstedt, MA

Latest:

Offer Patients Counseling on ADFs

Pharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.



Dana A. Brown, PharmD, BCPS

Latest:

Natural Products on Deck: Keeping Joints in the Game

Many patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.


Jack J. Chen, PharmD, BCPS, BCGP, FASCP, FCCP

Latest:

Parkinson's Disease Psychosis: A Pharmacist's Update of New Treatment Options

This Continuing Education activity is supported by an educational grant from Acadia Pharmaceuticals Inc.


Steven R. Peskin, MD, MBA, FACP

Latest:

Opioid-Induced Constipation: Considerations for Formulary Decision Makers

This activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.


Kevin Hirsch, MD

Latest:

Drivers of Change in Pharmacy Benefit Management

Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.


Michelle Byrne, PharmD, MSPBA

Latest:

Ivosidenib for Relapsed/Refractory Acute Myeloid Leukemia

On July 20, 2018, the FDA approved ivosidenib (Tibsovo) as a treatment option for adult patients with relapsed/refractory acute myeloid leukemia, specifically with a mutation in the IDH1 gene.


Aaron Wang, PharmD candidate

Latest:

Addressing HIV with Incarcerated Individuals Requires Understanding of PrEP

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.